β¨ Medicines Distribution Consents
1 OCTOBER NEW ZEALAND GAZETTE 3267
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Ibuprofen 200 mg | Capsule | R P Scherer Pty Limited, Huntingdale, Melbourne, Australia | Act-3 |
| Dexfenfluramine 15 mg | Capsule | Les Laboratories Servier, Gidy, Fleury-les-Aubrais, France or Alphapharm Pty Limited, Carole Park, Queensland, Australia | Adifax |
| Carboplatin 50 mg in 5 ml, 150 mg in 15 ml, 450 mg in 45 ml | Injection | Delta West Pty Limited, Bentley, Western Australia | Carboplatin injection |
| Cyclophosphamide monohydrate 100 mg, 200 mg, 500 mg, 1000 mg | Powder for reconstitution for injection | Pharmachemie BV, Waardeweg 78, Haarlem, The Netherlands, and Pharmachemie BV, Swensweg 5, Haarlem, The Netherlands | Cyclophosphamide |
| Cefazolin sodium 500 mg/10 ml, 1 g/10 ml, 500 mg/100 ml, 1 g/100 ml, 10 g/100 ml | Powder for reconstitution for injection (vials) | Lyphomed, Grand Island, New York, United States of America | Sterile Cefazolin Sodium |
| Naloxone hydrochloride 0.4 mg in 1 ml | Solution for injection | David Bull Laboratories Pty Limited, Mulgrave North, Victoria, Australia | Naloxone hydrochloride injection Elafth |
| Lithium succinate 8% w/w | Ointment | J Pickles & Sons, Knaresborough, Yorkshire, England | |
| Zinc sulphate 0.05% w/w | |||
| Chlorhexidine gluconate 0.01% w/v | Solution | Delta West Pty Limited, Bentley, Western Australia | Antiseptic Bladder Irrigation |
| Sodium valproate 200 mg, 500 mg | Enteric coated tablets | Pacific Pharmaceuticals Limited, Mount Wellington, Auckland | Epilim 200 Epicon 500 |
| Propafenone hydrochloride 150 mg, 300 mg | Tablets | Knoll, AG, Ludwigshafen, Germany | Rytmonorm |
| Vigabatrin 500 mg | Tablet | Merrell Dow France SA, Bourgoin-Jallieu, Cedex, France | Sabril |
Dated this 25th day of September 1992.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.
go8891
Consent to the Distribution of New Related Products
Pursuant to section 96 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new related products set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Chlorhexidine gluconate 0.5% w/w | Antiseptic solution | Johnson & Johnson Medical Pty Limited, North Ryde, New South Wales, Australia | Novacol Tincture |
| Paraffin liquid 95% v/v | Bath oil | Hamilton Laboratories Pty Limited, Adelaide, South Australia | Bath Oil |
Dated this 25th day of September 1992.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.
go8892
Consent to the Distribution of a Changed Medicine
Pursuant to section 24 (5) of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Nicotine 0.83 mg/cmΒ² | Patch | Kabi Pharmacia Operations AS, HillerΓΈd, Denmark | Nicorette Transdermal Delivery Service |
Dated this 25th day of September 1992.
C. LOVELACE, Director-General of Health, pursuant to delegation given by the Minister of Health on the 5th day of June 1991.
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1992, No 158
NZLII —
NZ Gazette 1992, No 158
β¨ LLM interpretation of page content
π₯
Consent to Distribution of New Medicines
(continued from previous page)
π₯ Health & Social Welfare25 September 1992
Medicines Act, New Medicines, Distribution
- C. Lovelace, Director-General of Health
π₯ Consent to the Distribution of New Related Products
π₯ Health & Social Welfare25 September 1992
Medicines Act, New Related Products, Distribution
- C. Lovelace, Director-General of Health
π₯ Consent to the Distribution of a Changed Medicine
π₯ Health & Social Welfare25 September 1992
Medicines Act, Changed Medicine, Distribution
- C. Lovelace, Director-General of Health